Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0000950170-24-095402

Director sold 183,834 shares at an average $42.85 ($7,877,091)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kersten Dirk Director 2024-08-08 Sale 10b5-1 −6,377 $40.74 $259,799 6,410,416 I: show line 1 in the form
Kersten Dirk Director 2024-08-08 Sale 10b5-1 −16,357 $42.97 $702,860 6,394,059 I: show line 2 in the form
Kersten Dirk Director 2024-08-08 Sale 10b5-1 −68,936 $42.87 $2,955,286 6,325,123 I: show line 3 in the form
Kersten Dirk Director 2024-08-09 Sale 10b5-1 −50,736 $42.55 $2,158,817 6,274,387 I: show line 4 in the form
Kersten Dirk Director 2024-08-09 Sale 10b5-1 −40,268 $43.44 $1,749,242 6,234,119 I: show line 5 in the form
Kersten Dirk Director 2024-08-09 Sale 10b5-1 −1,160 $44.04 $51,086 6,232,959 I: show line 6 in the form
Open-market sales · 183,834 sh · avg $42.85 · $7,877,091
Loading xslF345X05/ownership.xml…